Prostate biopsy: indications and technique.

PURPOSE The last decade has seen numerous modifications in the way prostate cancer is diagnosed. We review the current indications for and methods of prostate biopsy. MATERIALS AND METHODS The English language literature was reviewed regarding major indications for and methods of prostate biopsy. Pertinent peer reviewed articles were collated and analyzed. RESULTS The most widely accepted indication for prostate biopsy is a prostate specific antigen (PSA) value of greater than 4.0 ng./ml. However, some investigators advocate prostate biopsy for men with a PSA value in the 2.5 to 4.0 ng./ml. range, believing that use of this parameter results in detection of a greater number of cases of curable disease. Age specific PSA range, percent free PSA and presence of prostatic intraepithelial neoplasia or atypia are all considered to be relative indications for prostate biopsy. The current literature describes a trend toward increasing the number of cores obtained and the sites biopsied beyond those of the standard sextant technique. The additional cores in many series are obtained from more lateral regions of the gland. CONCLUSIONS Although several criteria are used as indications for initial prostate biopsy, all are based on PSA level and/or abnormal digital rectal examination. Future improvements in currently used prostate cancer markers may result in better selection of cases to biopsy. There is no universally accepted technique of prostate gland biopsy. The current literature supports use of more extensive biopsy techniques to increase the likelihood of prostate cancer detection.

[1]  D. Bostwick,et al.  Prostate biopsy interpretation. Current concepts, 1999. , 1999 .

[2]  R. B. Smith,et al.  The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. , 1994, The Journal of urology.

[3]  C. Amling,et al.  Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. , 2000, The Journal of urology.

[4]  W. Cooner,et al.  Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.

[5]  W. Fair,et al.  Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. , 1997, The Journal of urology.

[6]  W. Ellis,et al.  The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. , 1993, The Journal of urology.

[7]  P. Carroll,et al.  The significance of prostatic intra-epithelial neoplasia. , 1995, British journal of urology.

[8]  J. Trachtenberg,et al.  Adenocarcinoma of the Prostate , 1988 .

[9]  M. Benson,et al.  PSA density (PSAD). Role in patient evaluation and management. , 1993, The Urologic clinics of North America.

[10]  A. Partin,et al.  Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. , 1997, Urology.

[11]  D. Kapoor,et al.  Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. , 1998, Urology.

[12]  P. Carroll,et al.  The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. , 1993, The Journal of urology.

[13]  John T. Wei,et al.  The influence of prostate size on cancer detection. , 1995, Urology.

[14]  M. Terris,et al.  Limitations of transperineal ultrasound-guided prostate biopsies. , 1999, Urology.

[15]  J. Melamed,et al.  Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. , 1998, The Journal of urology.

[16]  D L McCullough,et al.  Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. , 1997, The Journal of urology.

[17]  W. Catalona,et al.  Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. , 1995, JAMA.

[18]  J. Richie,et al.  Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. , 2000, Urology.

[19]  D. Bostwick,et al.  Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. , 1995, The Journal of urology.

[20]  W. Catalona,et al.  Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.

[21]  Ximing J. Yang,et al.  Prostate Biopsy Interpretation , 1995 .

[22]  K C Shandera,et al.  Variability in patient preparation for prostate biopsy among American urologists. , 1998, Urology.

[23]  P. Walsh,et al.  The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. , 1999, The Journal of urology.

[24]  K. Badani,et al.  Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.

[25]  A. Zlotta,et al.  Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. , 1996, The Journal of urology.

[26]  W. Catalona,et al.  Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. , 1994, The Journal of urology.

[27]  R. Clements,et al.  Side effects and patient acceptability of transrectal biopsy of the prostate. , 1993, Clinical radiology.

[28]  E. Belgrano,et al.  [Transrectal ultrasound-guided biopsy of the prostate]. , 2000, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[29]  H. Stricker,et al.  Detection of non-palpable prostate cancer. A mathematical and laboratory model. , 1993, British journal of urology.

[30]  H. Carter A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: the only rational approach for men 50 years old and older. , 2000, Urology.

[31]  M. Terris,et al.  Original Articles: Prostate Cancer: Indications for Ultrasound Guided Transition Zone Biopsies in the Detection of Prostate Cancer , 1995 .

[32]  W. Catalona,et al.  Lowering PSA cutoffs to enhance detection of curable prostate cancer. , 2000, Urology.

[33]  R W Veltri,et al.  Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. , 2000, Urology.

[34]  D. Johnston,et al.  Comparison of prostate biopsy schemes by computer simulation. , 1999, Urology.

[35]  Fritz H. Schröder,et al.  Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer , 1998 .

[36]  M. Stampfer,et al.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.

[37]  M M Elhilali,et al.  Outcome of sextant biopsy according to gland volume. , 1997, Urology.

[38]  Experience with vasal sperm aspiration. , 1998, The Journal of urology.

[39]  J. Epstein,et al.  Follow-up of atypical prostate needle biopsies suspicious for cancer. , 1999, Urology.

[40]  M. Terris,et al.  Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. , 1998, The Journal of urology.

[41]  A. Reith,et al.  DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas. , 1993, Analytical and quantitative cytology and histology.

[42]  C. Olsson,et al.  Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum. , 1996, Urology.

[43]  P. Humphrey,et al.  Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. , 1995, The Journal of urology.

[44]  T. Stamey,et al.  Making the most out of six systematic sextant biopsies. , 1995, Urology.

[45]  W. Catalona,et al.  Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. , 1998, The Journal of urology.

[46]  F. Marshall,et al.  A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. , 2000, The Journal of urology.

[47]  J. Richie,et al.  Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. , 1994, The Journal of urology.

[48]  O. Nilsson,et al.  Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. , 1991, Clinical chemistry.

[49]  C. Cuny,et al.  Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer. , 1996, Urology.

[50]  P. Carroll,et al.  Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? , 2001, The Journal of urology.

[51]  E. Metter,et al.  Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.

[52]  H. D. de Koning,et al.  Prostate cancer detection at low prostate specific antigen. , 2000, The Journal of urology.

[53]  G N Collins,et al.  Multiple transrectal ultrasound-guided prostatic biopsies--true morbidity and patient acceptance. , 1993, British journal of urology.

[54]  W. Catalona,et al.  Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less. , 1999, The Journal of urology.

[55]  D. Ornstein,et al.  A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. , 2000, The Journal of urology.

[56]  K. Shinohara,et al.  Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. , 1996, The Journal of urology.

[57]  A. Partin,et al.  Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. , 1999, Urology.

[58]  Louis R Kavoussi,et al.  Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. , 1993, Urology.

[59]  W. Catalona,et al.  Longitudinal screening for prostate cancer with prostate-specific antigen. , 1996, JAMA.

[60]  P. Carroll,et al.  Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. , 2001, The Journal of urology.

[61]  J. Epstein,et al.  Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? , 2001, The Journal of urology.

[62]  A. Weaver,et al.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. , 2001, The Journal of urology.

[63]  M. Terris,et al.  Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. , 1997, The Journal of urology.

[64]  D. Ornstein,et al.  Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. , 1997, JAMA.

[65]  H. Korman,et al.  Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? , 2002, The Journal of urology.

[66]  K. Shinohara,et al.  The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. , 2000, The Journal of urology.

[67]  M. Terris,et al.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.

[68]  D. McCullough,et al.  Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy. , 1994, Urology.

[69]  D. McCullough,et al.  Prostate cancer diagnosed by the 5 region biopsy method is significant disease. , 1998, The Journal of urology.

[70]  W. Fair,et al.  Indications for transition zone biopsy in the detection of prostatic carcinoma. , 1997, The Journal of urology.

[71]  W. Catalona,et al.  Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. , 1995, The Journal of urology.

[72]  W. Ellis,et al.  Repeat prostate needle biopsy: who needs it? , 1995, The Journal of urology.

[73]  Jerome P. Richie,et al.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.

[74]  M. Soloway,et al.  Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods. , 2001, The Journal of urology.

[75]  L. Bégin,et al.  Value of systematic transition zone biopsies in the early detection of prostate cancer. , 1996, The Journal of urology.

[76]  D. Bostwick Prostatic intraepithelial neoplasia , 2000, Current urology reports.

[77]  L. Holmberg,et al.  Determinants of complications after multiple transrectal core biopsies of the prostate , 2004, European Radiology.

[78]  H. Nisenbaum,et al.  Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. , 1996, The Journal of urology.

[79]  C G Chute,et al.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. , 1993, JAMA.

[80]  B. Matlaga,et al.  Results of the 5 region prostate biopsy method: the repeat biopsy population. , 2002, The Journal of urology.

[81]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[82]  P. Walsh,et al.  Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. , 1997, The Journal of urology.

[83]  J. Oesterling,et al.  A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. , 1998, The Journal of urology.

[84]  D. Johnston,et al.  A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. , 2000, The Journal of urology.

[85]  J. Falcó,et al.  Massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. , 2000, Endoscopy.